VRTX icon

Vertex Pharmaceuticals
VRTX

Upgrade to unlock
Buy
Hold
Sell

9 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$477
10% upside
High target

9 analyst ratings

positive
4  neutral
44%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
UBS
UBS
Colin Bristow
67% 1-yr VRTX win rate
7 Nov ‘25 23 days ago
RBC Capital
RBC Capital
Brian Abrahams
4 Nov ‘25 26 days ago
Barclays
Barclays
Gena Wang
4 Nov ‘25 26 days ago
Stifel
Stifel
Paul Matteis
4 Nov ‘25 26 days ago
Morgan Stanley
Morgan Stanley
Terence Flynn
10 Oct ‘25 1 month ago
JP Morgan
JP Morgan
Jessica Fye
50% 1-yr VRTX win rate
8 Oct ‘25 1 month ago
Citigroup
Citigroup
Geoff Meacham
100% 1-yr VRTX win rate
2 Oct ‘25 1 month ago
Leerink Partners
Leerink Partners
David Risinger
100% 1-yr VRTX win rate
25 Sep ‘25 2 months ago
Evercore ISI Group
Evercore ISI Group
Liisa Bayko
100% 1-yr VRTX win rate
11 Sep ‘25 2 months ago
Raymond James
Raymond James
Danielle Brill
3 Sep ‘25 2 months ago